CD40LG and Alzheimer disease: Although none of the genes differed significantly post multiple testing correction, we noticed an increase in CD40 ligand (CD40L) in PBMCs sourced from both ε3ε4 and ε4ε4 AD patients compared to ε3ε3 AD patients (Fig. 4c-d).